HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV

Background & Aims: Millions of people worldwide are infected chronically with HBV, which results in significant morbidity and mortality. Therapeutic vaccination is a strategy that aims to induce functional cure by restoring cellular immunity to HBV. Previously we have shown the candidate HBV imm...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Tamsin Cargill, Paola Cicconi, Anthony Brown, Louise Holland, Benaka Karanth, Kathryn Rutkowski, Emily Ashwin, Reena Mehta, Senthil Chinnakannan, Sarah Sebastian, Louise Bussey, Henrik Sorensen, Paul Klenerman, Thomas Evans, Eleanor Barnes
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2023-11-01
Edice:	JHEP Reports
Témata:	Hepatitis B Vaccine Chimpanzee adenovirus Shark invariant chain
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2589555923002161
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!